Dow Chemical Co. is moving 800 workers by the end of next year to a new research-and-development facility on a sprawling campus that is also home to drug giant Pfizer Inc.Full story
Pfizer Inc. has agreed to pay almost $491 million to settle allegations it illegally marketed an organ transplant drug and will return more than $27 million to state health care programs, including about $700,000 to Oklahoma, a prosecutor said Tuesday. Full story
The cholesterol-lowering drug Lipitor has generated $106 billion for its manufacturer Pfizer over the past decade. But at the end of this month, Pfizer's patent expires and lower cost generic alternatives will go on the market. NBC’s Robert Bazell has more.
People walk past the Pfizer Inc. headquarters in New York, January 31, 2013. REUTERS/Brendan McDermid
People walk past the Pfizer Inc. headquarters in New York, in this file photo from January 31, 2013. Pfizer Inc reported second-quarter earnings slightly ahead of estimates July 30, 2013 as the largest U.S. drugmaker lines up a business split that could lead to the spinoff of its generics division.
Kathrin Jansen, senior vice president of Vaccine Research and Early Development at Pfizer Inc, poses for a portrait in one of her labs at Pfizer headquarters in Pearl River, New York, April 19, 2013. REUTERS/Carlo Allegri